The European Medicines Agency (EMA) has officially concluded its two-year tenure as chair of the International Coalition of Medicines Regulatory Authorities (ICMRA), with Executive Director Emer Cooke handing over the reins to Anthony Lawler. This transition marks a pivotal moment for ICMRA, which has established itself as a vital platform for the exchange of information and best practices among global regulatory bodies. During the ICMRA Summit 2025, attendees emphasized the critical role of regulators in disseminating reliable, evidence-based scientific information, reinforcing the importance of transparency in regulatory processes.
The implications of this leadership change extend beyond mere administrative shifts; it signals a continued commitment to enhancing global collaboration in pharmaceutical regulation. As Lawler steps into the role, stakeholders can anticipate a renewed focus on strategic leadership and active engagement among regulatory authorities, which may influence future regulatory frameworks and practices worldwide.
Start your 7-day trial and see what the database can do →
